SCHEMBL949067

SCHEMBL949067

c1[nH]nnc1-c1cnn[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL218983 0.75
SCHEMBL87533 0.72
SCHEMBL20523585 0.70
SCHEMBL17791784 0.69
SCHEMBL4065971 0.68 HCAR2 (0.46)
SCHEMBL29689434 0.67
Piperazine SCHEMBL27601703 0.67
SCHEMBL23641148 0.67 MEN1 (0.36)
SCHEMBL6050863 0.65
SCHEMBL28334937 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451279-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLS Akebia Therapeutics Inc. (US) 2012-05-16 EP claimed
WO-2011005330-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLS AKEBIA THERAPEUTICS INC. (US) 2011-01-13 WO claimed
US-20050272789-A1 Triazole-derived kinase inhibitors and uses thereof HALE MICHAEL R 2005-12-08 US disclosed